Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACOR
4726
CALL
DELISTED
Acorda Therapeutics
ACOR
| $172K | ﹤0.01% |
+67
| New | +$190K |
|
|
ALBO
4727
DELISTED
Albireo Pharma Inc
ALBO
| $172K | ﹤0.01% |
+6,700
| New | +$170K |
|
|
QEP
4728
PUT
DELISTED
QEP RESOURCES, INC.
QEP
| $172K | ﹤0.01% |
18,000
+11,900
| +195% | +$108K |
|
|
ERN
4729
DELISTED
Erin Energy Corp
ERN
| $172K | ﹤0.01% |
62,484
-20
| -0% | -$54 |
|
4730
Andersons Inc
ANDE
$2.38B
| $171K | ﹤0.01% |
5,511
+4,886
| +782% | +$163K |
|
4731
CALL
Celanese
CE
$4.73B
| $171K | ﹤0.01% |
1,600
-600
| -27% | -$63.8K |
|
4732
Erie Indemnity
ERIE
$13.1B
| $171K | ﹤0.01% |
1,399
+512
| +58% | +$62K |
|
4733
PUT
Fortune Brands Innovations
FBIN
$6.24B
| $171K | ﹤0.01% |
+2,925
| New | +$166K |
|
4734
Hackett Group
HCKT
$290M
| $171K | ﹤0.01% |
10,921
+8,820
| +420% | +$137K |
|
4735
Marcus Corp
MCS
$949M
| $171K | ﹤0.01% |
6,274
+4,609
| +277% | +$127K |
|
4736
CALL
Manulife Financial
MFC
$73.9B
| $171K | ﹤0.01% |
8,200
-24,200
| -75% | -$503K |
|
4737
Protagonist Therapeutics
PTGX
$8.83B
| $171K | ﹤0.01% |
8,216
+8,000
| +3,704% | +$142K |
|
4738
United States Lime & Minerals
USLM
$3.38B
| $171K | ﹤0.01% |
11,135
+10,910
| +4,849% | +$188K |
|
4739
Flotek Industries
FTK
$1.3B
| $170K | ﹤0.01% |
6,061
-2,832
| -32% | -$80.6K |
|
4740
1st Source
SRCE
$2.17B
| $170K | ﹤0.01% |
3,453
+2,099
| +155% | +$107K |
|
4741
PUT
Sysco
SYY
$40.3B
| $170K | ﹤0.01% |
2,800
-500
| -15% | -$28.3K |
|
4742
CALL
Titan International
TWI
$471M
| $170K | ﹤0.01% |
13,200
+4,400
| +50% | +$48.9K |
|
4743
Select Water Solutions
WTTR
$2.77B
| $170K | ﹤0.01% |
9,336
-7,842
| -46% | -$126K |
|
|
SDRL
4744
PUT
DELISTED
Seadrill Limited Common Stock
SDRL
| $170K | ﹤0.01% |
2,749
+1,697
| +161% | +$135K |
|
|
ELGX
4745
DELISTED
Endologix Inc
ELGX
| $170K | ﹤0.01% |
3,177
+1,143
| +56% | +$60.4K |
|
4746
City Holding Co
CHCO
$2.06B
| $168K | ﹤0.01% |
2,491
+2,091
| +523% | +$146K |
|
|
DHIL
4747
DELISTED
Diamond Hill
DHIL
| $168K | ﹤0.01% |
815
+739
| +972% | +$156K |
|
4748
Omeros
OMER
$916M
| $168K | ﹤0.01% |
8,647
+2,733
| +46% | +$51.2K |
|
4749
abrdn Physical Gold Shares ETF
SGOL
$7.25B
| $168K | ﹤0.01% |
13,300
| – | – |
|
|
EBSB
4750
DELISTED
Meridian Bancorp, Inc.
EBSB
| $168K | ﹤0.01% |
8,217
+5,052
| +160% | +$99.9K |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.